Baxter International (NYSE:BAX) Given Sell (D) Rating at Weiss Ratings

Key Points

• Baxter International received a "sell (d)" rating from Weiss Ratings, with other firms also downgrading their ratings to "hold".
• The company's stock has traded down to $22.74, with a market cap of $11.68 billion and a PE ratio of -75.80.
• Baxter reported Q2 earnings of $0.59 per share, missing the consensus estimate, with anticipated FY 2025 guidance of 2.420-2.520 EPS.

Baxter International (NYSE:BAX - Get Free Report)'s stock had its "sell (d)" rating reaffirmed by investment analysts at Weiss Ratings in a research report issued on Wednesday,Weiss Ratings reports.

A number of other research firms have also weighed in on BAX. Wall Street Zen lowered shares of Baxter International from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Wells Fargo & Company lowered their target price on shares of Baxter International from $33.00 to $24.00 and set an "equal weight" rating for the company in a research note on Friday, August 1st. Evercore ISI lowered their target price on shares of Baxter International from $33.00 to $31.00 and set an "outperform" rating for the company in a research note on Tuesday. Stifel Nicolaus reiterated a "hold" rating and set a $25.00 price objective (down from $36.00) on shares of Baxter International in a research note on Monday, August 4th. Finally, Morgan Stanley reduced their target price on shares of Baxter International from $28.00 to $27.00 and set an "underweight" rating for the company in a report on Tuesday, July 15th. Three research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $28.89.

Baxter International Stock Down 0.7%

NYSE BAX traded down $0.16 during mid-day trading on Wednesday, reaching $22.74. The stock had a trading volume of 4,822,995 shares, compared to its average volume of 5,490,715. The stock has a market cap of $11.68 billion, a PE ratio of -75.80, a price-to-earnings-growth ratio of 0.75 and a beta of 0.58. The company has a debt-to-equity ratio of 1.30, a current ratio of 2.30 and a quick ratio of 1.49. The company has a fifty day moving average price of $23.66 and a 200 day moving average price of $27.96. Baxter International has a 1 year low of $21.33 and a 1 year high of $38.28.

Baxter International (NYSE:BAX - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $0.59 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.60 by ($0.01). Baxter International had a negative net margin of 1.42% and a positive return on equity of 16.96%. The business had revenue of $2.81 billion for the quarter, compared to the consensus estimate of $2.82 billion. During the same period in the previous year, the firm earned $0.68 EPS. The company's revenue was up 4.3% on a year-over-year basis. Baxter International has set its Q3 2025 guidance at 0.580-0.620 EPS. FY 2025 guidance at 2.420-2.520 EPS. On average, research analysts expect that Baxter International will post 2.48 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in BAX. Zions Bancorporation National Association UT acquired a new stake in shares of Baxter International during the 1st quarter worth about $27,000. CoreFirst Bank & Trust purchased a new position in Baxter International in the 2nd quarter worth approximately $27,000. Rossby Financial LCC acquired a new position in shares of Baxter International in the 1st quarter valued at approximately $29,000. Creative Financial Designs Inc. ADV raised its position in shares of Baxter International by 169.6% during the 2nd quarter. Creative Financial Designs Inc. ADV now owns 984 shares of the medical instruments supplier's stock valued at $30,000 after acquiring an additional 619 shares in the last quarter. Finally, MTM Investment Management LLC bought a new position in Baxter International during the 2nd quarter worth $30,000. Institutional investors and hedge funds own 90.19% of the company's stock.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.